Eva‐Laure Matera - Concepedia

Author

Eva‐Laure Matera

Inserm ORCID

Also Known As

E. L. Matera, E.L. Matera, Eva-Laure Matera, Eva‐Laure Matera, Eva–Laure Matera, L Jordheim, Matera, Eva-Laure

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

Inserm Centre de Recherche en Cancérologie de Lyon Université Claude Bernard Lyon 1 Centre National de la Recherche Scientifique Hospices Civils de Lyon

About

Eva‐Laure Matera is an author at Inserm specializing in medicine, cancer research, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	675
2	Biochemistry	4	4	289
3	Natural Sciences	3	3	231
4	Health Sciences	1	1	23
5	Biomolecular Engineering	1	1	35

Eva‐Laure Matera

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Levels of Gemcitabine Transport and Metabolism Proteins Predict Survival Times of Patients Treated With Gemcitabine for Pancreatic Adenocarcinoma Raphaël Maréchal, Jean‐Baptiste Bachet, John R. Mackey, Gastroenterology Pancreatic CancerPatients TreatedMedicinePathologyGemcitabine Transport	2012	236
Antimitotic and Antiproliferative Activities of Chalcones: Forward Structure–Activity Relationship Ahcène Boumendjel, Julien Boccard, Pierre‐Alain Carrupt, Journal of Medicinal Chemistry PharmacotherapyK562 Leukemia CellsPharmaceutical ChemistryMedicinal ChemistryChaperones	2008	173
Adipose cells promote resistance of breast cancer cells to trastuzumab-mediated antibody-dependent cellular cytotoxicity Minh Ngoc Duong, Aurore Cleret, Eva‐Laure Matera, Breast Cancer Research	2015	102
Small Molecule Inhibitors of ERCC1-XPF Protein-Protein Interaction Synergize Alkylating Agents in Cancer Cells Lars Petter Jordheim, Khaled Barakat, Laurence Heinrich-Balard, Molecular Pharmacology	2013	88
Structure–activity relationship of natural and synthetic coumarins inhibiting the multidrug transporter P-glycoprotein Imad Raad, Raphaël Terreux, Pascal Richomme, Bioorganic & Medicinal Chemistry Structure–activity RelationshipMolecular PharmacologyPharmaceutical ScienceBiochemistryMedicine	2006	58
Exatecan Antibody Drug Conjugates Based on a Hydrophilic Polysarcosine Drug-Linker Platform Louise Conilh, Guy Fournet, Eric Fourmaux, Pharmaceuticals	2021	56
Tissue-nonspecific alkaline phosphatase is an anti-inflammatory nucleotidase Laurence Bessueille, Anne Briolay, Juna Como, Bone InflammationBiochemistryNatural SciencesTissue-nonspecific Alkaline PhosphataseReactive Oxygen Specie	2020	46
ADP ribosylation factor like 2 (Arl2) protein influences microtubule dynamics in breast cancer cells Anne Béghin, Stéphane Honoré, Celine Messana, Experimental Cell Research Protein InfluencesAdp Ribosylation FactorProtein FunctionBreast OncologyMedicine	2006	42
The acridone derivative MBLI-87 sensitizes breast cancer resistance protein-expressing xenografts to irinotecan Ophélie Arnaud, Ahcène Boumendjel, Annabelle Gèze, European Journal of Cancer Tumor BiologyBreast OncologyMedicineBreast CancerCancer Biology	2011	35
Expression of Arl2 is associated with p53 localization and chemosensitivity in a breast cancer cell line Anne Béghin, Eva‐Laure Matera, Stéphanie Brunet-Manquat, Cell Cycle	2008	31

Page 1